Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever?

Pediatrics

Volumn 97, Issue 6 II SUPPL., 1996, Pages 989-991

  Currie, Bart J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

benzathine penicillin G; prophylaxis; rheumatic fever

Indexed keywords

BENZATHINE PENICILLIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATIC FEVER; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; PENICILLIN G, BENZATHINE; RHEUMATIC FEVER;

EID: 0029929928     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH, Custer EA. Prevention of rheumatic fever. JAMA. 1950;143:151-153
2. Stollerman GH, Rusoff JH. Prophylaxis against Group A streptococcal infections in rheumatic fever patients. JAMA. 1952;150:1571-1575
3. Thomas CB, France RA. A preliminary report of the prophylactic use of sulfanilamide in patients susceptible to rheumatic fever. Bull Johns Hopkins Hosp. 1939;64:67-77
4. Feinstein AR, Wood HF, Epstein JA, Taranta A, Simpson R, Tursky E. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. N Engl J Med. 1959;260:697-702
5. Feinstein AR, Spagnuolo M, Jonas S, Kloth H, Tursky E, Levitt M. Prophylaxis of recurrent rheumatic fever. JAMA. 1968;206:565-568
6. WHO Study Group. Rheumatic fever and rheumatic heart disease. WHO technical report series no. 764. Geneva: World Health Organization; 1988
7. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation. 1988;78:1082-1086
8. Ginsburg CM, McCracken GH, Zeiwghaft TC. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children. Pediatrics. 1982;69:452-454
9. Kaplan EL, Berrios X, Speth J, Siefferman T, Guzman B, Quesny F. Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1 200 000 units. J Pediatr. 1989;115:146-150
10. Lue HC, Wu MH, Hsieh KH, Lin GJ, Hsieh RP, Chiou JF. Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs. J Pediatr. 1986;108:299-304
11. Padmavati S, Gupta V, Prakash K, Sharma KB. Penicillin for rheumatic fever prophylaxis: 3-weekly or 4-weekly schedule? J Assoc Physicians India. 1987;35:753-755
12. Plant AJ, Condon JR, Durling G. Northern Territory health outcomes, morbidity and mortality 1979-1991. Darwin, Australia: Northern Territory Department of Health and Community Services; 1995;112-113
13. Currie B. Medicine in tropical Australia. Med J Aust. 1993;158:609-615
14. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr. 1994;125:812-816
15. Ayoub EM. Prophylaxis in patients with rheumatic fever: every three or every four weeks? J Pediatr. 1989;115:89-91
16. Currie BJ, Burt T, Kaplan EL. Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Antimicrob Agents Chemother. 1994;38:1203-1204
17. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American Group A streptococcal isolates to eleven oral antibiotics. Pediatr Inject Dis J. 1994;13:630-635
18. Catanzaro FJ, Stetson CA, Morris AJ, et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med. 1954;17:749-756
19. Zaher SR, Kassem AS, Abou-Shleib H, El Kholy AG, Madkour A, Kaplan EL. Differences in serum penicillin concentrations following intramuscular injection of benzathine penicillin G (BPG) from different manufacturers. J Pharm Med. 1992;2:17-23
20. Cockshott WP, Thompson GT, Howlett LJ, Seeley ET. Intramuscular or intralipomatous injections, N Engl J Med. 1982;307:356-358
21. Currie B. Why does Australia have no national drug policy? Med J Aust. 1992;157:210